Study aims to determine whether genes affect Plavix effectiveness

04/19/2010 | News & Observer (Raleigh, N.C.), The

Researchers at the University of North Carolina at Chapel Hill launched a study to determine whether heart patients carry a genetic trait that affects their response to blood thinner Plavix. The scientists hope the trial will help doctors screen patients who would benefit from the treatment and clarify a metabolism warning from the FDA.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA